These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 2105890)
1. Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Vossen JM; Heidt PJ; van den Berg H; Gerritsen EJ; Hermans J; Dooren LJ Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):14-23. PubMed ID: 2105890 [TBL] [Abstract][Full Text] [Related]
2. Experimental and clinical gnotobiotics: influence of the microflora on graft-versus-host disease after allogeneic bone marrow transplantation. Heidt PJ; Vossen JM J Med; 1992; 23(3-4):161-73. PubMed ID: 1479298 [TBL] [Abstract][Full Text] [Related]
3. Management of bacterial and fungal infections in bone marrow transplant recipients and other granulocytopenic patients. Heidt PJ Cancer Detect Prev; 1988; 12(1-6):609-19. PubMed ID: 3052842 [TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal decontamination of dogs treated with total body irradiation and bone marrow transplantation. Vriesendorp HM; Heidt PJ; Zurcher C Exp Hematol; 1981 Oct; 9(9):904-16. PubMed ID: 7040095 [TBL] [Abstract][Full Text] [Related]
5. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. Rocha V; Wagner JE; Sobocinski KA; Klein JP; Zhang MJ; Horowitz MM; Gluckman E N Engl J Med; 2000 Jun; 342(25):1846-54. PubMed ID: 10861319 [TBL] [Abstract][Full Text] [Related]
10. Effects of bacterial naso-oropharyngeal colonisation on acute graft-versus-host disease in patients undergoing allogeneic bone marrow transplantation. Liu KL; Herbrecht R; Lioure B; Jaulhac B; Maloisel F; Dufour P; Bergerat JP; Oberling F Bone Marrow Transplant; 1995 Jan; 15(1):65-9. PubMed ID: 7742757 [TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367 [TBL] [Abstract][Full Text] [Related]
12. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft. Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557 [TBL] [Abstract][Full Text] [Related]
13. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704 [TBL] [Abstract][Full Text] [Related]